statistiche ricercatore

Continente	#
NA - Nord America	842
EU - Europa	566
AS - Asia	530
SA - Sud America	64
Continente sconosciuto - Info sul continente non disponibili	22
AF - Africa	16
OC - Oceania	2
Totale	2.042

Nazione	#
US - Stati Uniti d'America	808
IT - Italia	341
SG - Singapore	160
CN - Cina	150
VN - Vietnam	63
DE - Germania	47
HK - Hong Kong	46
BR - Brasile	43
GB - Regno Unito	39
BD - Bangladesh	29
KR - Corea	29
SE - Svezia	25
NL - Olanda	22
CA - Canada	21
FR - Francia	19
FI - Finlandia	18
RU - Federazione Russa	18
ID - Indonesia	10
ZA - Sudafrica	10
IN - India	8
CO - Colombia	7
CZ - Repubblica Ceca	7
IQ - Iraq	7
MX - Messico	6
LT - Lituania	5
ES - Italia	4
JP - Giappone	4
PK - Pakistan	4
AR - Argentina	3
CL - Cile	3
EC - Ecuador	3
IL - Israele	3
PL - Polonia	3
SI - Slovenia	3
UZ - Uzbekistan	3
AL - Albania	2
AU - Australia	2
AZ - Azerbaigian	2
DZ - Algeria	2
IE - Irlanda	2
MA - Marocco	2
PR - Porto Rico	2
PY - Paraguay	2
UA - Ucraina	2
XK - ???statistics.table.value.countryCode.XK???	2
AE - Emirati Arabi Uniti	1
AT - Austria	1
BB - Barbados	1
BE - Belgio	1
BG - Bulgaria	1
BM - Bermuda	1
BN - Brunei Darussalam	1
BO - Bolivia	1
CH - Svizzera	1
EE - Estonia	1
EG - Egitto	1
GL - Groenlandia	1
GR - Grecia	1
KG - Kirghizistan	1
LB - Libano	1
MD - Moldavia	1
MK - Macedonia	1
MN - Mongolia	1
MY - Malesia	1
NA - Namibia	1
NI - Nicaragua	1
OM - Oman	1
PE - Perù	1
PH - Filippine	1
QA - Qatar	1
RS - Serbia	1
SA - Arabia Saudita	1
SV - El Salvador	1
SY - Repubblica araba siriana	1
TR - Turchia	1
VE - Venezuela	1
Totale	2.022

Nome	#
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis	290
Chromosome 9p trisomy increases stem cells clonogenic potential and fosters T-cell exhaustion in JAK2-mutant myeloproliferative neoplasms	286
L’inibizione della migrazione di cellule CD14+ e CD34+ con un anticorpo anti-CD44 come nuovo approccio terapeutico per contrastare l’emopoiesi extramidollare in pazienti con mielofibrosi	275
Chromosome 9p Duplication Promotes T-Cell Exhaustion and Enhances Stem Cell Clonogenic Potential in JAK2-Mutant Myeloproliferative Neoplasms	273
The Response to Oxidative Damage Correlates with Driver Mutations and Clinical Outcome in Patients with Myelofibrosis	263
Inhibition of ERK1/2 signaling prevents bone marrow fibrosis by reducing osteopontin plasma levels in a myelofibrosis mouse model	260
Targeting exhausted cytotoxic T cells through CTLA‐4 inhibition promotes elimination of neoplastic cells in human myelofibrosis xenografts	191
CD44 Participates to Extramedullary Haematopoiesis Onset by Mediating the Interplay Between Monocytes and Haematopoietic Stem Cells in Myelofibrosis	152
Combined MEK and JAK inhibition reduces osteopontin plasma level and bone marrow fibrosis in a myelofibrosis mouse model	52
Totale	2.042

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2021/2022	65	0	0	0	2	9	2	2	4	12	10	6	18
2022/2023	92	8	9	10	5	6	4	0	8	10	8	5	19
2023/2024	161	16	2	13	22	14	7	13	19	3	7	19	26
2024/2025	518	11	8	4	21	93	61	50	34	51	20	97	68
2025/2026	904	86	45	67	91	111	45	122	41	98	93	57	48
2026/2027	282	29	57	79	117	0	0	0	0	0	0	0	0
Totale													2.042